Efficacy and safety of pegcetacoplan in kidney transplant recipients with recurrent C3G or primary IC-MPGN

Bomback, A. S., Daina, E., Remuzzi, G., Kanellis, J., Kavanagh, D., Pickering, M. C., Sunder-Plassmann, G., Walker, P. D., Wang, Z., Ahmad, Z., & Fakhouri, F. (2024). Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis. Kidney International Reports. https://doi.org/10.1016/j.ekir.2024.09.030
Authors:
Andrew S. Bomback
Erica Daina
Giuseppe Remuzzi
John Kanellis
David Kavanagh
Matthew C. Pickering
Gere Sunder–Plassmann
Patrick D. Walker
Zhongshen Wang
Zurish Ahmad
Fádi Fakhouri
Affiliated Authors:
Andrew S. Bomback
Author Keywords:
c3 glomerulopathy
complement
immune complex membranoproliferative glomerulonephritis
pegce- tacoplan
proteinuria
pegcetacoplan
Publication Type:
Article
Unique ID:
10.1016/j.ekir.2024.09.030
Publication Date:
Data Source:
OpenAlex

Record Created: